Viewing Study NCT00950404


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-05-31 @ 8:08 AM
Study NCT ID: NCT00950404
Status: COMPLETED
Last Update Posted: 2021-02-01
First Post: 2009-07-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bioavailability Pharmacokinetic Formulation View